Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PARP inhibitors for targeted treatment in ovarian cancer.

× No keyword cloud information.

8 in total

Review 1. Where Do We Stand on the Integration of PARP Inhibitors for the Treatment of Breast Cancer?

Authors: Narjust Duma; Kelly C Gast; Grace M Choong; Roberto A Leon-Ferre; Ciara C O'Sullivan
Journal: Curr Oncol Rep Date: 2018-06-08 Impact factor: 5.075

2. Deep exploration of PARP inhibitors in breast cancer: monotherapy and combination therapy.

Authors: Zheling Chen; Xiao Wang; Xiao Li; Yucheng Zhou; Ke Chen
Journal: J Int Med Res Date: 2021-02 Impact factor: 1.671

3. Comprehensive analysis of serum tumor markers and BRCA1/2 germline mutations in Chinese ovarian cancer patients.

Authors: Hongyu Deng; Ming Chen; Xinwu Guo; Jianfu Heng; Xunxun Xu; Limin Peng; Hui Jiang; Guoli Li; Julia X Day; Jinliang Li; Dongyong Shan; Yinghua Li; Yanjie Zhou; Bin Liu; Lizhong Dai; Xiaochun Wang; Jun Wang
Journal: Mol Genet Genomic Med Date: 2019-04-10 Impact factor: 2.183

4. MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis: implication of Wnt/catenin beta and MEK/ERK signaling pathways.

Authors: Ruitao Zhang; Huirong Shi; Fang Ren; Wei Feng; Yuan Cao; Gailing Li; Zheying Liu; Pengcheng Ji; Minghui Zhang
Journal: J Exp Clin Cancer Res Date: 2019-12-16

5. The disruption of the CCDC6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma.

Authors: Francesco Morra; Francesco Merolla; Giovanna Damia; Francesca Ricci; Silvia Varricchio; Gennaro Ilardi; Laura Arenare; Daniela Califano; Virginia Napolitano; Robert Fruscio; Rosa Marina Melillo; Luca Palazzo; Angela Celetti
Journal: J Exp Clin Cancer Res Date: 2022-08-13

6. Olaparib, a PARP-1 inhibitor, protects retinal cells from ocular hypertension-associated oxidative damage.

Authors: Yuting Yang; Jihong Wu; Wei Lu; Yiqin Dai; Youjia Zhang; Xinghuai Sun
Journal: Front Cell Dev Biol Date: 2022-08-26

7. Prognostic Evidence of the miRNA-Based Ovarian Cancer Signature MiROvaR in Independent Datasets.

Authors: Loris De Cecco; Marina Bagnoli; Paolo Chiodini; Sandro Pignata; Delia Mezzanzanica
Journal: Cancers (Basel) Date: 2021-03-27 Impact factor: 6.639

8. ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer.

Authors: Youkun Jie; Lu Ye; He Chen; Xiaohong Yu; Li Cai; Wenfeng He; Yonghui Fu
Journal: Bioengineered Date: 2020-12 Impact factor: 3.269

8 in total